CLDN5 and autoimmune pancreatitis: Similarly, PPP1R16B, PECAM1 and CLDN5 are vital for maintaining endothelial barrier function, with their downregulation indicating a compromised barrier, potentially impacting AIP pathophysiology [27, 28, 29, 30].